SecBot SecBot
Insider Cluster (2 insiders) ·Filed May 21, 2026

RPRX

Royalty Pharma plc
NEUTRAL
Impact 2/10
Horizondays Processed5mo ago
Insider cluster: 2 insiders, $883K total
Actionable Insight • Neutral

The dollar amount is too small to signal any material change in business outlook. Monitor upcoming quarterly earnings for any fundamental shifts; these sales are routine and non-actionable.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$54.50
T+0 close · May 21, 2026 · via day close
Latest settled
+9.52%
T+60 · $59.69
Vs SPY
+6.33%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 22 $54.50entry
  2. T+1 · 6mo ago −1.17%α −1.76% · $53.86
  3. T+5 · 6mo ago +1.25%α −0.41% · $55.18
  4. T+20 · 5mo ago −1.83%α −0.42% · $53.50
  5. T+60 · 3mo ago +9.52%α +6.33% · $59.69

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two insiders at Royalty Pharma sold a combined $883K in open-market transactions over a one-week window. The sales represent ~0.003% of the $30.6B market cap, a trivial amount that is routine and non-informative. No material business catalyst is evident from the filing.

Key Financial Metrics

Direction
selling
Total Value
$883.0K
Insiders
2

Key Facts

  • Director Norden Gregory sold 3,000 shares at ~$53.00 for $161K on 2026-05-14.
  • EVP Marshall Urist sold 13,684 shares at ~$52.75 for $722K on 2026-05-20.
  • Total insider sales of $883K represent ~0.003% of RPRX's $30.6B market cap.
  • No insider purchases were reported in the cluster window.
  • Recent 30-day insider activity includes 4 prior sales totaling $3.2M, consistent with routine liquidity-driven selling.

Financial Impact

Total insider sales of $883K, or ~0.003% of market cap, economically negligible.

insider holdings

Risk Factors

  • Insider sales could increase if the stock continues to appreciate, but no bearish signal is present here.
  • No identifiable catalyst from this filing alone.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-RPRX-1779412846308

Track record

23 reports on RPRX

Performance horizon

5 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +15.20% at T+60 after the May 6, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry price pending
  2. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $67.57 to $68.97 Now $69.31 +2.58% ▲ +2.07% −1.22% vs SPY
  3. Nov 4, 202612d ago 8-K Neutral 5/10 No price data
  4. Nov 4, 202612d ago Press Release Bullish 6/10 Entry $67.56 to $70.01 Now $69.31 +2.59% ▲ +3.63% +4.54% vs SPY
  5. Sep 30, 20266w ago Insider Cluster Bearish 5/10 Entry $57.63 to $56.21 Now $69.31 −20.27% ▲ +2.46% +3.77% vs SPY
  6. Sep 4, 202610w ago Press Release Bearish 5/10 Entry $60.59 to $58.47 Now $69.31 −14.39% ▲ +3.50% +2.38% vs SPY
  7. Aug 19, 202612w ago Insider Cluster Neutral 3/10 Entry $60.57 to $61.92 Now $69.31 +14.44% ▲ +2.24% +1.12% vs SPY
  8. Aug 12, 202613w ago 144 Neutral 3/10 Entry $58.56 to $60.58 Now $69.31 +18.36% ▲ +3.45% +5.41% vs SPY
  9. Aug 5, 202614w ago 8-K Bullish 6/10 Entry $57.75 to $59.22 Now $69.31 +20.02% ▲ +2.55% +2.19% vs SPY
  10. Jul 2, 202619w ago Insider Cluster Neutral 2/10 Entry $57.77 to $57.96 Now $69.31 +19.98% ▲ +0.33% −0.60% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens Wed (13h 28m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 21, 2026